Rosa Nadal Rios

Rosa Nadal Rios, MD, PhD is an Associate Professor in the Department of Medicine's Division of Hematology and Oncology at the University of Washington School of Medicine and Associate Professor in the Clinical Research Division at Fred Hutchinson Cancer Center. She practices at Fred Hutchinson Cancer Center's South Lake Union Clinic specializing in genitourinary cancers.

Education:

• MD, PhD: Universitat Autònoma de Barcelona
• Residency: Hospital de Sant Pau Universitat Autònoma de Barcelona (Internal Medicine and Medical Oncology)
• Fellowship: Johns Hopkins University (Prostate Cancer Program, Genitourinary Medical Oncology)
• Fellowship: National Institutes of Health (Medical Oncology and Hematology)

Dr. Nadal's research focuses on novel targeted therapeutics and immunotherapy-based treatments for urologic cancers, with particular expertise in bladder cancer and developing cancer cell therapies for solid malignancies. She pioneered the first clinical trial of engineered T-cells targeting human endogenous retrovirus E for kidney cancer. Her work bridges translational research and clinical application, emphasizing innovative approaches to difficult-to-treat genitourinary tumors. As a native Spanish speaker, she actively advocates for Spanish-speaking patients' inclusion in clinical trials.

Her recent publications demonstrate significant contributions to understanding surgical timing and complications during the COVID-19 pandemic, reflecting her broader commitment to optimizing cancer care delivery during public health crises. These works appear in high-impact journals including British Journal of Surgery and Anaesthesia.

Professional Activities:

• Active clinical trials investigator at Fred Hutch
• Member of multi-disciplinary genitourinary cancer team
• Advocate for Spanish-speaking patient inclusion in clinical research
• Collaborator in international surgical outcomes research